Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Gross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Cost of Revenue (2016 - 2026)

Amphastar Pharmaceuticals has reported Cost of Revenue over the past 13 years, most recently at $97.4 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 144.2% year-over-year to $97.4 million; the TTM value through Dec 2025 reached $286.1 million, up 337.08%, while the annual FY2025 figure was $363.8 million, 862.46% up from the prior year.
  • Cost of Revenue for Q4 2025 was $97.4 million at Amphastar Pharmaceuticals, up from $93.2 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $97.4 million in Q4 2025 and troughed at -$220.4 million in Q4 2024.
  • A 5-year average of $11.0 million and a median of $32.3 million in 2021 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 1663.02% in 2021 and later plummeted 385.73% in 2023.
  • Year by year, Cost of Revenue stood at -$155.9 million in 2021, then skyrocketed by 140.96% to $63.9 million in 2022, then plummeted by 385.73% to -$182.5 million in 2023, then dropped by 20.82% to -$220.4 million in 2024, then surged by 144.2% to $97.4 million in 2025.
  • Business Quant data shows Cost of Revenue for AMPH at $97.4 million in Q4 2025, $93.2 million in Q3 2025, and $10.2 million in Q2 2025.